Advances in artificial intelligence, personalised medicine, digital health, and emerging therapies are transforming how organisations operate and compete within the Pharmaceutical sector. At the same time, demand for highly specialised scientific, technical, and leadership talent continues to grow, while the supply of these skills remains limited. This means that traditional recruitment approaches are often no longer enough. To remedy this, companies should make use of Talent Intelligence to gain understanding of talent markets, anticipate future workforce needs, and build sustainable talent pipelines before critical skills gaps emerge.
Pharma Faces Constant Transformation
The pharmaceutical industry is experiencing unprecedented change, driven by scientific innovation, digital transformation, AI adoption, personalised medicine, and evolving regulatory requirements. As organisations race to bring new therapies to market faster and more efficiently, the pace of change shows no signs of slowing.
Digital transformation is playing a particularly significant role in reshaping the industry. Advances in cloud computing, automation, and artificial intelligence are fundamentally changing how pharmaceutical companies conduct research and development. For example, GSK recently utilised cloud and AI robotic systems to build one of the most advanced autonomous labs in the world. The facility enables AI-guided experiments to run with minimal human intervention, significantly increasing productivity and reducing screening timelines by more than 50% (source).
These advances are not only transforming how work is done, but also the skills organisations need to succeed. To fully realise the benefits of AI and other emerging technologies, pharmaceutical companies must ensure they have access to the talent capable of developing, implementing, and managing these innovations.
It is now essential that talent strategies are able to anticipate workforce changes before they impact business performance. Companies need to understand which capabilities will be required in the future and ensure they can access those skills ahead of demand.
This is why workforce planning has become a strategic priority. Organisations that proactively prepare for uncertainty by anticipating future capability requirements (whether human or technological) are better positioned to remain resilient, accelerate innovation, and outperform competitors during periods of change and volatility. In contrast, businesses that lack visibility into future talent needs risk creating skills gaps that can delay critical projects, slow product development, and hinder growth.
If you would like to read more about this topic, read our article: Workforce Planning in an Age of Uncertainty.
Critical Skills Are Becoming Scarcer
As the pharmaceutical industry continues to evolve, organisations increasingly require skills in areas that were not traditionally associated with the sector, including data science, artificial intelligence, machine learning, software engineering, cloud computing, and cybersecurity.
These capabilities are becoming increasingly important across drug discovery, clinical development, manufacturing, and commercial operations. However, many of these skills are already in short supply. Developing expertise in highly specialised scientific and technical fields often requires years of education, training, and hands-on experience, creating a limited talent pool at a time when demand continues to accelerate.
The challenge is further compounded by the fact that many of these professionals have opportunities across multiple industries. A data scientist, AI specialist, or cloud engineer may receive offers from pharmaceutical companies, technology firms, financial institutions, and start-ups alike. This means pharma companies are no longer competing solely with other life sciences businesses for talent; they are also competing with a much broader range of employers seeking the same expertise.
Traditional Vacancy-Led Recruitment Is No Longer Enough
A vacancy-led approach can restrict visibility into wider talent market dynamics. Waiting until a vacancy arises before beginning a search may leave organisations competing for an already limited pool of available candidates. It also leaves little time to understand emerging skill trends, monitor competitor activity, or identify future talent risks. As a result, organisations may find themselves repeatedly reacting to skills shortages rather than preparing for them.
This reactive model can also be inefficient. Recruitment teams often spend considerable time searching for candidates who could have been identified, mapped, and nurtured months or even years earlier. Building relationships only when a vacancy arises means organisations frequently start from scratch, competing for talent at the point of highest demand.
At the same time, expectations of talent acquisition teams are changing. Business leaders increasingly look to TA functions not only to fill open positions, but also to provide strategic workforce insights that support long-term business goals. They want visibility into where critical talent exists, how competitor hiring activity is evolving, and which skills will be needed in the future.
To overcome these challenges, many pharmaceutical organisations are investing in talent intelligence; using market data and workforce insights to better understand talent availability, emerging skills, competitor activity, and future hiring risks.
Leading TA Teams Are Building Pipelines Before Demand Exists
Rather than waiting for vacancies to arise, high-performing TA functions are working closely with business leaders to anticipate future workforce needs based on organisational strategy, growth plans, and emerging market trends.
Talent intelligence plays a critical role in enabling this shift. By providing greater visibility into the talent market, it helps organisations understand where critical skills exist, how talent pools are evolving, and where future shortages may emerge. TA teams can use these insights to map global talent pools, identify emerging skills, monitor competitor hiring activity, and assess the availability of talent in key markets.
Perhaps most importantly, talent intelligence enables organisations to engage with potential candidates long before a role becomes available through talent pipeline engagement. Building relationships with passive talent allows employers to develop talent communities around critical skill areas, creating a pipeline of qualified candidates who are already familiar with the organisation and its opportunities. As a result, organisations can reduce time-to-hire, improve quality of hire, and respond more quickly when hiring demand arises.
This approach is particularly valuable for niche scientific, technical, and leadership positions, where suitable candidates may be scarce and recruitment processes can take months to complete. By identifying and engaging talent early, organisations are better positioned to secure the expertise they need before competitors do.
Talent Intelligence Supports Succession, Diversity and Workforce Planning
Talent intelligence is not only valuable for recruitment. It also provides evidence-based insights that can support broader workforce decisions across succession planning, diversity, and long-term workforce strategy.
Succession planning is particularly important within pharmaceutical organisations. Many critical scientific, technical, and leadership roles require years of specialist experience and institutional knowledge. By providing visibility into both internal and external talent pools, talent intelligence helps organisations identify potential successors, understand where capability gaps may emerge, and reduce the risk associated with key personnel changes.
The increasing complexity of the pharmaceutical landscape also makes workforce planning more challenging. Growth in areas such as cell and gene therapy, artificial intelligence, real-world evidence, and digital health is creating demand for skills that may not exist in sufficient numbers within current workforces. The ABPI’s Life Sciences 2035 report forecasts that the UK sector will require around 70,000 additional employees by 2035, highlighting the scale of the workforce challenge facing the industry.
As demand for digital, data, engineering, and advanced scientific capabilities continues to grow, organisations need a clearer understanding of where these skills exist, how talent markets are evolving, and which capabilities will become critical in the years ahead. Talent intelligence provides the insight needed to make these decisions proactively rather than reactively.
Talent intelligence can also support diversity objectives by helping organisations look beyond traditional hiring channels and talent networks. By providing a broader view of global talent markets, it enables TA teams to identify underrepresented talent pools, benchmark diversity representation across functions and geographies, and make more informed decisions about where and how to engage candidates.
In addition, talent intelligence offers valuable insight into geographic talent availability, compensation trends, competitor hiring activity, and future workforce risks. These insights can inform decisions around site locations, workforce investment, and build-versus-buy talent strategies, helping organisations make more effective long-term workforce decisions.
As a result, talent intelligence is increasingly becoming a foundational capability for workforce planning within the pharmaceutical sector. By creating stronger alignment between talent acquisition, HR, and business strategy, organisations can move beyond short-term hiring needs and build the workforce required to support future scientific innovation and commercial success.
Conclusion: Proactive Beats Reactive
The pharmaceutical industry is evolving rapidly, creating new demands for specialist skills and increasing competition for talent. At the same time, organisations are being asked to navigate digital transformation, scientific innovation, and changing workforce requirements while continuing to deliver business growth.
In this environment, reactive recruitment is becoming increasingly difficult to sustain. Organisations that wait until a vacancy arises often find themselves competing for scarce talent at the point of highest demand, while those that take a more proactive approach are better positioned to anticipate future workforce needs and secure critical skills ahead of competitors.
This is why talent intelligence is becoming such a valuable capability for pharmaceutical organisations. By providing greater visibility into talent markets, emerging skills, workforce risks, and future talent needs, it enables organisations to make more informed decisions about recruitment, succession planning, diversity, and workforce strategy.
As the pace of change continues to accelerate, the most successful organisations will be those that move beyond filling vacancies and begin building the workforce they will need for the future.
Henley Insights Group: How we can help
At Henley Insights Group, we help pharmaceutical and life sciences organisations make more informed talent decisions through data-driven talent intelligence and market insight.
Whether you are looking to understand the availability of specialist skills, map global talent pools, benchmark competitor hiring activity, support workforce planning, or build proactive talent pipelines, our research provides the intelligence needed to support strategic decision-making.
Our tailored talent intelligence solutions help organisations:
- Identify and map critical talent pools across global markets
- Understand emerging skills and future workforce trends
- Benchmark talent availability, diversity, and compensation
- Support succession planning and workforce strategy
- Build proactive talent pipelines for hard-to-fill roles
- Reduce hiring risk through evidence-based talent insights
By combining deep research expertise with a strong understanding of the life sciences sector, we help organisations move beyond reactive recruitment and develop workforce strategies that support long-term growth, innovation, and business success.
To learn more about how Henley Insights Group can support your talent intelligence strategy, get in touch.